UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13E-3/A
(Amendment No. 3)
RULE 13e-3 TRANSACTION STATEMENT
(Pursuant to Section 13(e) of the Securities Exchange Act of 1934)
BlueLinx Holdings Inc.
(Name of the Issuer)
BlueLinx Holdings Inc.
(Name of Person(s) Filing Statements)
Common Stock, $0.01 Par Value
(Title of Class of Securities)
09624H109
(CUSIP Number)
Dean A. Adelman
Chief Administrative Officer
BlueLinx Holdings Inc.
4300 Wildwood Parkway
Atlanta, Georgia 30339
(770) 953-7000
(Name, address and telephone number of person authorized to receive
notices and communications on behalf of the persons filing statement)
With copies to:
|
|
|
Sara Epstein, Esq.
BlueLinx Corporation
4300 Wildwood Parkway
Atlanta, Georgia 30339
(770) 953-7000
|
|
Mark L. Hanson, Esq.
Jones Day
1420 Peachtree St., N.E.
Atlanta, Georgia 30309
(404) 521-3939 |
This statement is filed in connection with (check the appropriate box):
|
|
|
|
|
o
|
|
a.
|
|
The filing of solicitation materials or an information statement
subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the
Securities Exchange Act of 1934. |
|
|
|
|
|
o
|
|
b.
|
|
The filing of a registration statement under the Securities Act of 1933. |
|
|
|
|
|
þ
|
|
c.
|
|
A tender offer. |
|
|
|
|
|
o
|
|
d.
|
|
None of the above. |
Check the following box if the soliciting materials or information statement referred to in
checking box (a) are preliminary copies: o
Check the following box if the filing is a final amendment reporting the results of the
transaction: þ
CALCULATION OF FILING FEE
|
|
|
|
|
|
|
Transaction Valuation (1): $58,361,748.00
|
|
|
Amount of Filing Fee: $4,161.19 |
|
|
|
|
|
(1) |
|
Estimated solely for the purpose of calculating the amount of the filing fee in accordance
with the Securities Exchange Act of 1934, based on the product of (i) $4.00, which is the
tender offer price per share, and (ii) 14,590,437, which is the number of shares of common
stock, par value $0.01 per share, outstanding as of August 12, 2010, and eligible to be
tendered in the tender offer. |
|
þ |
|
Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify
the filing with which the offsetting fee was previously paid. Identify the previous filing by
registration statement number, or the Form or Schedule and the date of its filing. |
|
|
|
|
|
Amount previously paid:
|
|
$4,161.19 |
|
|
Filing Party:
|
|
Cerberus APB Investors LLC and Cerberus Capital Management, L.P.
|
Form or registration no.:
|
|
Schedule TO-T/A
|
Date Filed:
|
|
September 23, 2010.
|
INTRODUCTION
This Amendment No. 3 to Rule 13e-3 Transaction Statement on Schedule 13E-3, together with the
exhibits hereto (the Transaction Statement), is being filed by BlueLinx Holdings Inc., a Delaware
corporation (BlueLinx or the Company), the issuer of the common stock that is the subject of
the Rule 13e-3 transaction to amend and supplement Item 16. Exhibits of the Rule 13e-3
Transaction Statement on Schedule 13E-3 filed by the Company on September 27, 2010, as supplemented
on October 4, 2010 and as further supplemented on October 6, 2010. BlueLinx, as the filing person,
is the subject company.
This Transaction Statement relates to the offer by Cerberus ABP Investor LLC (CAI), a
Delaware limited liability company and a wholly-owned subsidiary of Cerberus Capital Management,
L.P. (Cerberus Capital), pursuant to which CAI has offered to purchase at a price of $4.00 per
share (the Offer Price), in cash, without interest and less any applicable withholding taxes,
shares of the common stock, par value $0.01 per share, of the Company (the Shares) not owned by
CAI, subject to the conditions set forth in the Offer to Purchase, as supplemented by the Second
Supplement to Offer to Purchase, dated September 22, 2010 (as further amended or supplemented, the
Offer to Purchase), and in the related Letter of Transmittal (together with any amendments or
supplements from time to time thereto, the Schedule TO), filed by CAI and Cerberus Capital with
the Securities and Exchange Commission (the Commission).
The information contained in the Schedule TO and Schedule 14D-9 filed by BlueLinx with the
Commission on August 13, 2010, as amended and supplemented by Amendments No. 1, No. 2, No. 3 and
No. 4 (the Schedule 14D-9) is incorporated by reference herein, and, except as described below,
the responses to each Item in this Transaction Statement are qualified in their entirety by the
information contained in the Schedule TO and Schedule 14D-9. All information contained in this
Transaction Statement concerning the Company, Cerberus Capital or CAI has been provided by such
person and not by any other person.
Item 16. Exhibits.
Item 16 is hereby amended to add exhibit (a)(1)(X) and exhibit (a)(2)(A)(v).
|
|
|
Exhibit No. |
|
Description |
|
|
|
(a)(1)(X)
|
|
Text of Press Release issued by CAI on October 19, 2010
announcing termination of the Offer (incorporated by
reference to Exhibit (a)(1)(xxv) to Schedule TO-T/A Amendment
No. 10, filed by CAI on October 19, 2010). |
|
|
|
(a)(2)(A)(v)
|
|
Solicitation/Recommendation Statement (Amendment No. 4) on
Schedule 14D-9 filed by the Company on October 19, 2010. |